Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non-Small Cell Lung Cancer

PURPOSE. Significant advances in the systemic management of metastatic non-small cell lung cancer (NSCLC) have occurred over the past decade, with options now including multiple lines of chemotherapy, epidermal growth factor receptor inhibitors, and antiangiogenic agents. Improvements in overall sur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yu, Joanne L., Simmons, Christine, Victor, J. Charles, Han, Dolly, Hogeveen, Sophie, Leighl, Natasha, Verma, Sunil
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2011
Assuntos:
Lung Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228167/
https://ncbi.nlm.nih.gov/pubmed/21835896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0079
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados